论文信息 - Comparison of the EORTC QLQ‐BM22 and the BOMET‐QOL quality of life questionnaires in patients with bone metastases

Comparison of the EORTC QLQ‐BM22 and the BOMET‐QOL quality of life questionnaires in patients with bone metastases

Bone metastases are a common complication of advanced cancer and often result in a decrease in patients' quality of life. Very few specific modules have been created to accurately assess quality of life in this patient group. The purpose of this study was to compare two questionnaires, the European Organization for Research and Treatment of Cancer quality of life questionnaire for patients with bone metastases (EORTC QLQ‐BM22) and the bone metastases quality of life questionnaire (BOMET‐QOL.

[1] Liying Zhang,et al. International field testing of the reliability and validity of the EORTC QLQ‐BM22 module to assess health‐related quality of life in patients with bone metastases , 2012, Cancer.

[2] A. Bottomley,et al. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases , 2009, Expert review of pharmacoeconomics & outcomes research.

[3] Liying Zhang,et al. Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases. , 2009, European journal of cancer.

[4] A. Bezjak,et al. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. , 2009, European journal of cancer.

[5] X. Badia,et al. Impact of skeletal complications on patients’ quality of life, mobility, and functional independence , 2008, Supportive Care in Cancer.

[6] X. Badia,et al. Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia , 2007 .

[7] A. Bottomley,et al. Quality of life and symptom end points in palliative bone metastases trials. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).